Industries de la santé
22 Février 2018
All countries in the seven major markets (7MM*), with the exception of Germany, will see an increase in the diagnosed prevalence cases of Crohn’s disease. France is projected to have the highest Annual Growth Rate (AGR) of diagnosed prevalent cases of Crohn’s disease at 4.04%, almost double the overall AGR of the 7MM at 2.09%. Germany, in contrast with the other markets, will see a... |Plus d'articles...
- GenSight Biologics : GS010 dans Ophthalmology
- Debiopharm poursuit le combat contre les résistances aux antibiotiques avec un investissement dans ABAC Therapeutics Inc
- Digital health in immunology had a vast impact on a myriad of healthcare sectors in 2017
- Sensorion présente des résultats positifs inédits pour le SENS-401au MidWinter Meeting de l'ARO